Introduction
Methylmercury poisoning, which causes neurological symptoms, is known as Minamata disease. It happens after regularly eating seafood that has been seriously infected. In the 1950s, when a chemical factory released significant amounts of mercury compounds into Minamata Bay, individuals in Japan were ill for the first time with Minamata illness.
What Is the Minamata Disaster?
There were several small fishing communities on the Shiranui Sea's edge, close to Minamata, Japan. Naturally, a lot of seafood was consumed in these villages. The villagers started noticing their cats were acting strangely and falling into the sea in the middle of the 1950s. Some individuals believed the cats were attempting suicide. Sometime later, it seemed as though a strange illness was spreading. The residents claimed that their lips and limbs were numb. Some others reported vision or hearing issues. Others experienced arm and leg tremors, trouble walking, and even brain damage. Additionally, some humans acted oddly and shouted out of control, much like the cats. Their neural system was under some sort of stress. The residents' and cats' fish-based diets appeared to be a pattern among individuals exhibiting symptoms, giving experts reason to believe the fish in Minamata Bay were being poisoned. High levels of mercury poisoning were finally identified as the illness's cause by Kumamoto University researchers in July 1959, and the condition was subsequently given the name Minamata disease. The Chisso Corporation's sizable petrochemical factory in Minamata was instantly suspected. Chisso refuted the accusations and kept producing without altering its manufacturing process. Chisso persisted in denying any connection and that its mercury waste was causing any illnesses. It was ultimately calculated that Chisso Corporation had discharged 82 tons of mercury compounds into Minamata Bay.
Poisoned ladies gave birth to poisoned children while mercury dumping was still going on. These kids have severe birth defects, including twisted limbs, mental retardation, blindness, and hearing. In 1959, the Minamata fisherman started to oppose the Chisso Corporation. They compelled Chisso to stop disposing of harmful trash and pay them for their diseases. In response, Chisso attempted to reach agreements with those harmed by mercury poisoning using legal documents that said the company would pay out for people's ailments but would not assume any further responsibility. Many people signed the papers because they believed it was their only chance to receive compensation.
What Are the Clinical Manifestations of Minamata Disease?
A poisoning condition known as Minamata disease occurs when methylmercury damages the nervous system, particularly the central nervous system. It has been proved that the state is distinct from inorganic mercury poisoning, which harms kidneys, among other organs, and that it does not damage any other organs but the neurological system. The main signs and symptoms include:
-
Sensory disturbance in the distal portions of the four extremities.
-
Cerebellar ataxia (incapacity to coordinate muscular action due to cerebellar illness or damage).
-
Bilateral concentric contraction of the visual field (visual field defect).
-
Disturbed ocular (eye) movement.
-
Hearing impairment.
-
Equilibrium disturbance caused by the CNS, etc.
Clinically, there are a variety of signs and symptoms that manifest. Additionally, because the mother was exposed to methylmercury while pregnant, fetal Minamata disease has been recorded, which manifests as deficits comparable to infantile cerebral paralysis (injury to or abnormal growth in the brain regions responsible for movement control).
In the early stages of the Minamata disease outbreak, some individuals displayed all of the main signs and symptoms, and some were fatal. However, many patients may only include some significant symptoms and indicators at a time.
What Is the Pathophysiology of Minamata Disease?
When the amount of methylmercury (the causal substance) stored within the body reaches the threshold value for the onset, Minamata disease may occur, similar to other types of poisoning. As methylmercury is released from the body at the same time it is taken in, it will not build up in the body more than the allowable cumulative amount corresponding to the amount of continuous intake, provided that a certain amount of the substance is continued to be taken in. "IPCS Environmental Health Criteria 101 Methylmercury," published by WHO in 1990, supports these conclusions.
How Is Minamata Disease Diagnosed?
The diagnosis of Minamata disease is made for people exposed to methylmercury based on the diagnostic criteria, which is composed of combinations of signs and symptoms to increase the probability of decision because other illnesses can also bring on each neurological sign and symptom of the disease. While diagnosing a normal patient with all primary symptoms and indications is straightforward, incomplete or moderate forms of the disease may make it challenging to differentiate from other illnesses.
How Is Minamata Disease Treated?
Rapid detection is crucial, according to research, and the initial Minamata disease outbreak would have been considerably smaller if precautions had been taken to prevent contamination at the outset. There is not much information available on how to handle methylmercury toxicity. The primary therapy methods consist of the following:
-
Supportive treatment.
-
Removal of the offending factor.
However, Minamata disease's neurological side effects frequently have irreversible repercussions, making patients incurable.
The Minamata Convention on Mercury was established by the United Nations in 2013 to address the fundamental problem of Minamata disease by sustainable development goals.
An international agreement on mercury, called the Minamata Convention, was made to safeguard humans from exposure to mercury and its compounds. To do this, the treaty specified many measures, including:
-
Regulating mercury trade and supply.
-
Restrict the sources of mercury.
-
Regulating mercury or mercury compounds-using processes, such as gold mining.
-
Regulating items with additional mercury.
What Are the After Effects of Minamata Disease?
People in Minamata Bay continue to experience the effects of the methylmercury poisoning event despite decades of restoration attempts by the United Nations Environment Program (UNEP). According to a variety of studies, fetuses may have begun to develop Minamata sickness while still inside the uterus, in addition to those who consumed the fish directly. People at the time believed the placenta would safeguard them. However, researchers have now thoroughly proved the notion that methylmercury toxicity could spread through the womb as infants are delivered with disorders resembling cerebral palsy. According to UNEP, human activity has increased mercury levels by about 450 percent beyond their normal levels during the previous few decades. Given the knowledge that is currently accessible, it is becoming more and more crucial to take action to lessen mercury poisoning and the pollution that enters water bodies and the rest of the ecosystem.
Conclusion
Finally, the unfortunate occurrence of Minamata's illness serves as a reminder of the grave implications of toxic exposure and environmental contamination. It has had a significant effect on those who are afflicted, their families, and the community as a whole. There are many different Minamata disease symptoms, which can include everything from minor neurological impairments to serious disabilities and even death. To stop the spread of Minamata illness and safeguard vulnerable communities, it is essential to keep monitoring and addressing the sources of mercury exposure. The occurrence of this crippling condition must also be decreased by public education about the dangers of mercury exposure and seafood consumption.
